News & Articles

Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions

FoundationOne Liquid CDx analyzes more than 300 cancer-related genes and multiple genomic signatures to inform treatment decisions for all solid tumor cancers

Combining image analysis with structured reporting, the software aims to improve and accelerate the detection of the virus

Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%

The real-time PCR workflow has a capacity of up to 6,000 tests per day per system, and demonstrated 100% agreement with authorized nasopharyngeal assays

QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing, whereas QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research

Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season

The kits aim to detect traces of SARS-CoV-2 virus on surfaces such as plastics, ceramics and stainless steel

Regeneron will distribute REGN-COV2 in the U.S. and Roche will be responsible for distribution outside the U.S.

The test outperforms other molecular tests with a low detection limit of 15 GEC/reaction (250 GEC/ml of sample) and a robust control system

The consortium aims to determine the dynamics, function and potential for therapeutic intervention of the RNA and protein structures of SARS-CoV-2

IgM assay has 95.51% positive predictive value even when disease incidence is only 3%

Used to empower clinicians to quickly prescribe treatment regimens for multidrug-resistant TB, the test could help fill a critical gap that is jeopardizing global TB targets

Connecting the scientific community with two new online content-packed events

Dr. Jeremy Hirota takes us through the technology behind his translational research program for respiratory health

The latest technologies, up-to-date methods and key case studies to help improve the sustainability of your lab

The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings

BD Kiestra InoqulA system is available in Europe (CE marked)

The new reagent kits aim to make whole genome sequencing more accessible and affordable for labs of all sizes

This powerful new solution aims to provide more accurate COVID-19 antibody detection

Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing

Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing

Join us on Wednesday, August 26, to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours